MétaCan
Menu
Back to cohort
Record W4390187836 · doi:10.1016/j.anai.2023.12.023

Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

2023· article· en· W4390187836 on OpenAlexafffund
Luis Pérez de Llano, Ghislaine Scélo, Giorgio Walter Canonica, Wenjia Chen, William Henley, Désirée Larenas‐Linnemann, Matthew Peters, Paul Pfeffer, Trung N. Tran, Charlotte Suppli Ulrik, Todor A. Popov, Mohsen Sadatsafavi, Mark Hew, Jorge Máspero, Peter G. Gibson, George Christoff, J. Mark FitzGerald, Carlos A. Torres‐Duque, Celeste Porsbjerg, Nikolaos G. Papadopoulos, Andriana Ι. Papaioannou, Enrico Heffler, Takashi Iwanaga, Mona Al‐Ahmad, Piotr Kuna, João Fonseca, Riyad Al‐Lehebi, Chin Kook Rhee, Mariko Siyue Koh, Borja G. Cosío, Diahn‐Warng Perng, Bassam Mahboub, Andrew Menzies‐Gow, David J. Jackson, John Busby, Liam G. Heaney, Pujan H. Patel, Eileen Wang, Michael E. Wechsler, Alan Altraja, Lauri Lehtimäki, Arnaud Bourdin, Leif Bjermer, Lakmini Bulathsinhala, Victoria Carter, Ruth Murray, Aaron Beastall, Eve Denton, David Price

Bibliographic record

VenueAnnals of Allergy Asthma & Immunology · 2023
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsUniversity of British Columbia
FundersSanofi GenzymeEisai CanadaGenentechGrifolsEisaiOptimum Patient CareAllergy TherapeuticsCovis PharmaDanoneUCB PharmaSeqirusRegeneron PharmaceuticalsTeva Pharmaceutical IndustriesGilead SciencesEli Lilly and CompanyAstraZenecaChiesi FarmaceuticiSanofiGlaxoSmithKlinePfizer
KeywordsMedicineAsthmaExacerbationCohortAsthma exacerbationsInternal medicineImmunology

Abstract

fetched live from OpenAlex

Background There is little agreement on clinically useful criteria for identifying real-world responders to biologic treatments for asthma. Objective To investigate the impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in adults with severe asthma. Methods This was a longitudinal, cohort study across 22 countries participating in the International Severe Asthma Registry (https://isaregistries.org/) from May 2017 to January 2023. Change in four asthma domains (exacerbation rate, asthma control, long-term oral corticosteroid [LTOCS] dose, and lung function) was assessed from biologic initiation to one year post-treatment (minimum 24 weeks). Pre- to post-biologic changes for responders and non-responders were described along a categorical gradient for each domain derived from pre-biologic distributions (exacerbation rate: 0 to 6+/year; asthma control: well-controlled to uncontrolled; LTOCS: 0 to >30 mg/day; ppFEV1: <50 to ≥80%). Results Percentage of biologic responders (i.e., those with a category improvement pre- to post-biologic) varied by domain and increased with greater pre-biologic impairment, increasing from 70.2 to 90.0% for exacerbation rate, 46.3 to 52.3% for asthma control, 31.1 to 58.5% for LTOCS daily dose, and 35.8 to 50.6% for ppFEV1. The proportion of patients showing improvement post-biologic tended to be greater for anti–IL-5/5R compared to anti-IgE for exacerbation, asthma control, and ppFEV1 domains, irrespective of pre-biologic impairment. Conclusion Our results provide realistic outcome-specific post-biologic expectations for both physicians and patients, will be foundational to inform future work on a multi-dimensional approach to define and assess biologic responders and response, and may enhance appropriate patient selection for biologic therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.028

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.012
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.038
GPT teacher head0.298
Teacher spread0.260 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueAnnals of Allergy Asthma & ImmunologySame topicAsthma and respiratory diseasesFrench-language works237,207